Equities research analysts at StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.
Aethlon Medical Price Performance
NASDAQ:AEMD opened at $0.40 on Wednesday. The company has a market capitalization of $5.62 million, a PE ratio of -0.08 and a beta of 1.74. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35. The stock’s 50 day moving average price is $0.41 and its 200 day moving average price is $0.61.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last announced its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the business earned ($1.30) EPS. As a group, sell-side analysts anticipate that Aethlon Medical will post -1.1 EPS for the current fiscal year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
See Also
- Five stocks we like better than Aethlon Medical
- What does consumer price index measure?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- P/E Ratio Calculation: How to Assess Stocks
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
